TIMP2 and frontotemporal dementia: Tissue inhibitor of metalloproteinases 2 (TIMP2) is associated with various neuropathological conditions and has been demonstrated to reduce TIMP2 levels in the plasma of patients with frontotemporal dementia [50, 51].